BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
26.080 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
26.080 |
Evidence |
|
MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
26.080 |
Evidence |
|
COPE |
COPE: Coatomer subunit epsilon |
COPB2 |
COPB2: Coatomer subunit beta' |
26.080 |
Evidence |
|
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
GNB2 |
GNB2: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 |
26.080 |
Evidence |
|
EIF4G3 |
EIF4G3: Eukaryotic translation initiation factor 4 gamma 3 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
26.050 |
Evidence |
|
IMPDH2 |
IMPDH2, IMPD2: Inosine-5'-monophosphate dehydrogenase 2 |
CRKRS |
CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 |
26.050 |
Evidence |
|
CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
26.050 |
Evidence |
O
|
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
BRIP1 |
BRIP1, BACH1, FANCJ: Fanconi anemia group J protein |
26.010 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
26.010 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
26.010 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SCARB2 |
SCARB2, CD36L2, LIMPII: Lysosome membrane protein 2 |
26.010 |
Evidence |
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
26.010 |
Evidence |
|
CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
26.010 |
Evidence |
|
NMT1 |
NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
26.010 |
Evidence |
|
AKAP8 |
AKAP8, AKAP95: A-kinase anchor protein 8 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
26.010 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
26.010 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
26.010 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
26.010 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
26.010 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FGFR2 |
IPI00010777 |
25.960 |
Evidence |
|
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
25.960 |
Evidence |
|
FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
25.960 |
Evidence |
|